Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Phyllodes Tumor 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × Catheterization × Clear all
NCT04976257 2023-04-07

Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion

University of California, San Francisco

Phase EARLY_PHASE1 Completed
5 enrolled
Genitourinary

Prostatic Neoplasms

NCT03030677 2020-09-09

ETCI

Kasr El Aini Hospital

Phase NA Completed
80 enrolled

Phyllodes Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡